
A study involving 2,733 participants found that genetic ancestry influences the association between APOE ε4 and Alzheimer's disease biomarkers. The effect of APOE ε4 on plasma pTau217 levels was approximately 2.5 times greater in individuals with predominantly European ancestry than in those with African ancestry. The findings highlight the importance of considering genetic ancestry alongside APOE genotype when interpreting blood-based biomarkers for Alzheimer's disease.
Like
Save
Share